168 related articles for article (PubMed ID: 36721896)
21. Early detection of pancreatic cancer.
Garg SK; Chari ST
Curr Opin Gastroenterol; 2020 Sep; 36(5):456-461. PubMed ID: 32657789
[TBL] [Abstract][Full Text] [Related]
22. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
23. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.
Zhu L; Mao H; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1793. PubMed ID: 35396932
[TBL] [Abstract][Full Text] [Related]
24. Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
Stenzinger A; Cuffel B; Paracha N; Vail E; Garcia-Foncillas J; Goodman C; Lassen U; Vassal G; Sullivan SD
Oncologist; 2023 May; 28(5):e242-e253. PubMed ID: 36961477
[TBL] [Abstract][Full Text] [Related]
25. Can a Broad Molecular Screen Based on Circulating Tumor DNA Aid in Early Cancer Detection?
Fiala C; Diamandis EP
J Appl Lab Med; 2020 Nov; 5(6):1372-1377. PubMed ID: 33057613
[TBL] [Abstract][Full Text] [Related]
26. Early detection of pancreatic cancer: why, who, and how to screen.
Klapman J; Malafa MP
Cancer Control; 2008 Oct; 15(4):280-7. PubMed ID: 18813195
[TBL] [Abstract][Full Text] [Related]
27. Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions.
Zhu W; Love K; Gray SW; Raz DJ
Clin Lung Cancer; 2023 May; 24(3):209-217. PubMed ID: 36797152
[TBL] [Abstract][Full Text] [Related]
28. Early detection of pancreatic cancer using DNA-based molecular approaches.
Singhi AD; Wood LD
Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):457-468. PubMed ID: 34099908
[TBL] [Abstract][Full Text] [Related]
29. [Expert consensus of Oncology Committee of Chinese Medical Association in early diagnosis and treatment of pancreatic cancer].
Early Diagnosis and Treatment Group, the Oncology Committee of Chinese Medical Association
Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):706-712. PubMed ID: 32988150
[TBL] [Abstract][Full Text] [Related]
30. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
31. The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm.
Klein EA; Beer TM; Seiden M
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626398
[TBL] [Abstract][Full Text] [Related]
32. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
33. Precision oncology for breast cancer through clinical trials.
Blucher AS; Mills GB; Tsang YH
Clin Exp Metastasis; 2022 Feb; 39(1):71-78. PubMed ID: 33950412
[TBL] [Abstract][Full Text] [Related]
34. The future of colorectal cancer research: an interview with Hans Schmoll.
Schmoll HJ
Future Oncol; 2020 Oct; 16(29):2269-2271. PubMed ID: 33074748
[No Abstract] [Full Text] [Related]
35. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
36. The future of blood-based biomarkers for the early detection of breast cancer.
Loke SY; Lee ASG
Eur J Cancer; 2018 Mar; 92():54-68. PubMed ID: 29413690
[TBL] [Abstract][Full Text] [Related]
37. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.
Singha M; Pu L; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
BMC Cancer; 2022 Nov; 22(1):1211. PubMed ID: 36434556
[TBL] [Abstract][Full Text] [Related]
38. Update on urine as a biomarker in cancer: a necessary review of an old story.
Zhang W; Zhang XJ; Chao SY; Chen SJ; Zhang ZJ; Zhao J; Lv YN; Yao JJ; Bai YY
Expert Rev Mol Diagn; 2020 May; 20(5):477-488. PubMed ID: 32212972
[No Abstract] [Full Text] [Related]
39. Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.
Marcus PM; Pashayan N; Church TR; Doria-Rose VP; Gould MK; Hubbard RA; Marrone M; Miglioretti DL; Pharoah PD; Pinsky PF; Rendle KA; Robbins HA; Roberts MC; Rolland B; Schiffman M; Tiro JA; Zauber AG; Winn DM; Khoury MJ
Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1449-1455. PubMed ID: 27507769
[TBL] [Abstract][Full Text] [Related]
40. Screening for Pancreatic Cancer.
Ngamruengphong S; Canto MI
Surg Clin North Am; 2016 Dec; 96(6):1223-1233. PubMed ID: 27865274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
